Remove Equity Remove Incubator Remove Pricing Remove San Diego
article thumbnail

Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More

Xconomy

The nation’s biggest annual cancer meeting took place in Chicago, while biotech’s trade group held its annual confab in San Francisco. Plans for new incubators were announced in two different cities. The new prices don’t reflect rebates and discounts. Ed Silverman at STAT reported the analyst note first.

article thumbnail

Southern California needs to find its hub for it to develop its own tech ecosystem

TechCrunch LA

Our research revealed a saturation level causing unprecedented challenges, starting with exorbitant housing prices and runaway operating costs that accelerate a startup’s “burn rate”—its monthly spending. Suster has also noted for years that the region produces more technology doctorates than any other geography in the United States.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes

Xconomy

billion acquisition of San Diego’s Auspex Pharmaceuticals last year. A company official told Xconomy the drug would be priced in line with standard of care enzyme replacement therapy, which costs around $300,000 per patient, per year. The drug has a list price of $69,350 per patient, per year.

article thumbnail

This Week in Venture Capital – Episode 4

Both Sides of the Table

Wildfire was one of the darlings of the fbFund incubator program. Summit is a hugely respected firm in Silicon Valley and a long-term “institution&# but they’re better known as more of a “private equity&# investor meaning that they do later stage investments in much larger companies that are profitable. OpenCandy.